ELK3 and Alzheimer disease: We also explored the upstream transcriptional regulators whose targets were significantly enriched in coexpression modules associated with metabolic shifts in endothelial cells (Figs. 4, 6), and by analysis of their gene expression levels we found that Lef1, Elk3 and Fosl1 were significantly decreased in stroke and AD.